Effect of translocation defective reverse transcriptase inhibitors on the activity of n348i, A connection subdomain drug resistant HIV-1 reverse transcriptase mutant

Cellular and Molecular Biology

Volumn 58, Issue 1, 2012, Pages 187-195

  Michailidis, E ^a   Singh, K ^a   Ryan, E M ^a   Hachiya, A ^a   Ong, Y T ^a   Kirby, K A ^a   Marchand, B ^a   Kodama, E N ^b   Mitsuya, H ^c,d   Parniak, M A ^e   Sarafianos, S G ^a,f  

^a UNIVERSITY OF MISSOURI   (United States)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f University of Missouri   (United States)

Author keywords

Antivirals; EFdA; ENdA; HIV 1; N348I; Reverse transcriptase; Translocation defective reverse transcriptase inhibitors

Indexed keywords

4' ETHYNYL 2 AMINO 2' DEOXYADENOSINE TRIPHOSPHATE; 4' ETHYNYL 2 FLUORO 2' DEOXYADENOSINE TRIPHOSPHATE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL RESISTANCE; ARTICLE; ENZYME ACTIVITY; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; NONHUMAN; POLYMERIZATION; WILD TYPE;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HIV REVERSE TRANSCRIPTASE; HIV-1; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84872479301     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T940     Document Type: Article

References (71)

1. Arion, D., N. Kaushik, S. McCormick, G. Borkow, and M. A. Parniak. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochem. 1998,37:15908-15917.
2. Bauman, J. D., K. Das, W. C. Ho, M. Baweja, D. M. Himmel, A. D. Clark, Jr., D. A. Oren, P. L. Boyer, S. H. Hughes, A. J. Shatkin, and E. Arnold. Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Nucleic Acids Res. 2008, 36:5083-5092.
3. Biaglow, J. E., and A. V. Kachur. The generation of hydroxyl radicals in the reaction of molecular oxygen with polyphosphate complexes of ferrous ion. Radiat Res. 1997, 148:181-187.
4. Biondi, M. J., G. L. Beilhartz, S. McCormick, and M. Gotte. N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiation. J Biol Chem.2010, 285 (35):26966-26975.
5. Boyer, P. L., S. G. Sarafianos, E. Arnold, and S. H. Hughes. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J Virol. 2001, 75:4832-4842.
6. Brehm, J. H., D. Koontz, J. D. Meteer, V. Pathak, N. Sluis-Cremer, and J. W. Mellors. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine. J Virol. 2007, 81:7852-7859.
7. Das, K., J. Ding, Y. Hsiou, A. D. Clark, Jr., H. Moereels, L. Koymans, K. Andries, R. Pauwels, P. A. Janssen, P. L. Boyer, P. Clark, R. H. Smith, Jr., M. B. Kroeger Smith, C. J. Michejda, S. H. Hughes, and E. Arnold. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. J Mol Biol. 1996, 264:1085-1100.
8. Delviks-Frankenberry, K. A., G. N. Nikolenko, R. Barr, and V. K. Pathak. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance. J Virol. 2007, 81:6837-6845.
9. Dharmasena, S., Z. Pongracz, E. Arnold, S. G. Sarafianos, and M. A. Parniak. 3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase. Biochem. 2007, 46:828-836.
10. Ehteshami, M., G. L. Beilhartz, B. J. Scarth, E. P. Tchesnokov, S. McCormick, B. Wynhoven, P. R. Harrigan, and M. Gotte. Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms. J. Biol.Chem. 2008, 283:22222-22232.
11. Goff, S. P. Retroviral reverse transcriptase: synthesis, structure, and function. J Acquir Immune Defic Syndr. 1990, 3:817-831.
12. Gotte, M., J. W. Rausch, B. Marchand, S. Sarafianos, and S. F. Le Grice. Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions. Biochim Biophys Acta. 2010, 1804:1202-1212.
13. Hachiya, A., E. N. Kodama, S. G. Sarafianos, M. M. Schuckmann, Y. Sakagami, M. Matsuoka, M. Takiguchi, H. Gatanaga, and S. Oka. Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J. virol. 2008, 82:3261-3270.
14. Hachiya, A., E. N. Kodama, M. M. Schuckmann, K. A. Kirby, E. Michailidis, Y. Sakagami, S. Oka, K. Singh, and S. G. Sarafianos. K70Q adds high-level tenofovir resistance to «Q151M complex» HIV reverse transcriptase through the enhanced discrimination mechanism. PloS one. 2011,6:e16242.
15. Hachiya, A., K. Shimane, S. G. Sarafianos, E. N. Kodama, Y. Sakagami, F. Negishi, H. Koizumi, H. Gatanaga, M. Matsuoka, M. Takiguchi, and S. Oka. Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients. Antiviral Res. 2009, 82:115-121.
16. Jacobo-Molina, A., J. Ding, R. G. Nanni, A. D. Clark, Jr., X. Lu, C. Tantillo, R. L. Williams, G. Kamer, A. L. Ferris and P. Clark. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. PNAS. 1993, 90:6320-6324.
17. Julias, J. G., M. J. McWilliams, S. G. Sarafianos, W. G. Alvord, E. Arnold, and S. H. Hughes. Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity. J Virol. 2003, 77:8548-8554.
18. Kawamoto, A., E. Kodama, S. G. Sarafianos, Y. Sakagami, S. Kohgo, K. Kitano, N. Ashida, Y. Iwai, H. Hayakawa, H. Nakata, H. Mitsuya, E. Arnold, and M. Matsuoka. 2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. Int J Biochem Cell Biol. 2008, 40:2410-2420.
19. Kodama, E. I., S. Kohgo, K. Kitano, H. Machida, H. Gatanaga, S. Shigeta, M. Matsuoka, H. Ohrui, and H. Mitsuya. 4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro. Antimicrob Agents Chemother. 2001, 45:1539-1546.
20. Kohlstaedt, L. A., J. Wang, J. M. Friedman, P. A. Rice, and T. A. Steitz. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 1992, 256:1783-1790.
21. Marchand, B., and M. Gotte. Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase. Implications for polymerase translocation and drug resistance. J Biol Chem. 2003, 278:35362-35372.
22. Menendez-Arias, L., and B. Berkhout. Retroviral reverse transcription. Virus Res. 2008,134:1-3.
23. Meyer, P. R., S. E. Matsuura, A. M. Mian, A. G. So, and W. A. Scott. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol Cell. 1999, 4:35-43.
24. Meyer, P. R., S. E. Matsuura, A. G. So, and W. A. Scott. Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc Nat Acad Sci USA. 1998, 95:13471-13476.
25. Meyer, P. R., S. E. Matsuura, A. A. Tolun, I. Pfeifer, A. G. So, J. W. Mellors, and W. A. Scott. Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother. 2002, 46:1540-1545.
26. Michailidis, E., B. Marchand, E. N. Kodama, K. Singh, M. Matsuoka, K. A. Kirby, E. M. Ryan, A. M. Sawani, E. Nagy, N. Ashida, H. Mitsuya, M. A. Parniak, and S. G. Sarafianos. Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor. J Biol Chem. 2009, 284:35681-35691.
27. Nikolenko, G. N., K. A. Delviks-Frankenberry, S. Palmer, F. Maldarelli, M. J. Fivash, Jr., J. M. Coffin, and V. K. Pathak. Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance. Proc Nat Acad Sci USA. 2007, 104:317-322.
28. Nikolenko, G. N., K. A. Delviks-Frankenberry, and V. K. Pathak. A novel molecular mechanism of dual resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J Virol. 2010, 84:5238-5249.
29. Nikolenko, G. N., S. Palmer, F. Maldarelli, J. W. Mellors, J. M. Coffin, and V. K. Pathak. Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc Nat Acad Sci USA. 2005, 102:2093-2098.
30. Ohrui, H., S. Kohgo, H. Hayakawa, E. Kodama, M. Matsuoka, T. Nakata, and H. Mitsuya. 2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma. Nucleic Acids Symp Ser (Oxf) 2006, 1-2.
31. Ren, J., R. Esnouf, A. Hopkins, C. Ross, Y. Jones, D. Stammers, and D. Stuart. The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design. Structure. 1995, 3:915-926.
32. Ren, J., C. Nichols, L. Bird, P. Chamberlain, K. Weaver, S. Short, D. I. Stuart, and D. K. Stammers. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J Mol Biol. 2001, 312:795-805.
33. Sarafianos, S. G., A. D. Clark, Jr., S. Tuske, C. J. Squire, K. Das, D. Sheng, P. Ilankumaran, A. R. Ramesha, H. Kroth, J. M. Sayer, D. M. Jerina, P. L. Boyer, S. H. Hughes, and E. Arnold. Trapping HIV-1 reverse transcriptase before and after translocation on DNA. J Biol Chem. 2003, 278:16280-16288.
34. Sarafianos, S. G., K. Das, A. D. Clark, Jr., J. Ding, P. L. Boyer, S. H. Hughes, and E. Arnold. Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. Proc Nat Acad Sci USA. 1999, 96:10027-10032.
35. Sarafianos, S. G., K. Das, S. H. Hughes, and E. Arnold. Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Curr Opin Struct Biol. 2004, 14:716-730.
36. Sarafianos, S. G., S. H. Hughes, and E. Arnold. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs. Int J Biochem Cell Biol. 2004, 36:1706-1715.
37. Sarafianos, S. G., B. Marchand, K. Das, D. M. Himmel, M. A. Parniak, S. H. Hughes, and E. Arnold. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol. 2009, 385:693-713.
38. Schuckmann, M. M., B. Marchand, A. Hachiya, E. N. Kodama, K. A. Kirby, K. Singh, and S. G. Sarafianos. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine. J Biol Chem 285:38700-38709.
39. Singh, K., B. Marchand, K. A. Kirby, E. Michailidis, and S. G. Sarafianos. 2010. Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase. Viruses 2:606-638.
40. Sluis-Cremer, N., D. Arion, and M. A. Parniak. 2000. Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Cell Mol Life Sci. 57:1408-1422.
41. Smerdon, S. J., J. Jager, J. Wang, L. A. Kohlstaedt, A. J. Chirino, J. M. Friedman, P. A. Rice, and T. A. Steitz. 1994. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc Nat Acad Sci USA. 91:3911-3915.
42. Wang, J., S. J. Smerdon, J. Jager, L. A. Kohlstaedt, P. A. Rice, J. M. Friedman, and T. A. Steitz. 1994. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc Nat Acad Sci USA. 91:7242-7246.
43. Yap, S. H., C. W. Sheen, J. Fahey, M. Zanin, D. Tyssen, V. D. Lima, B. Wynhoven, M. Kuiper, N. Sluis-Cremer, P. R. Harrigan, and G. Tachedjian. 2007. N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance. PLoS Med 4:e335.
44. Singh, M. P., and Kumar, V., Biodegradation of vegetable and agrowastes by Pleurotus sapidus: A noble strategy to produce mushroom with enhanced yield and nutrition. Cell. Mol. Biol. 2012, 58 (1): 1-7.
45. Pandey, V. K., Singh, M.P., Srivastava, A. K., Vishwakarma S. K., and Takshak, S., Biodegradation of sugarcane bagasse by white rot fungus Pleurotus citrinopileatus. Cell. Mol. Biol. 2012, 58 (1): 8-14.
46. Ruhal, A., Rana, J. S., Kumar S., and Kumar, A., Immobilization of malate dehydrogenase on carbon nanotubes for development of malate biosensor. Cell. Mol. Biol. 2012, 58 (1): 15-20.
47. Vishwakarma, S. K., Singh, M. P., Srivastava A.K. and Pandey, V. K., Azo dye (direct blue) decolorization by immobilized extracellular enzymes of Pleurotus species. Cell. Mol. Biol. 2012, 58 (1): 21-25.
48. Dash, S. K., Sharma, M., Khare, S. and Kumar, A., rmpM gene as a genetic marker for human bacterial meningitis. Cell. Mol. Biol. 2012, 58 (1): 26-30.
49. Bertoletti, F., Crespan, E. and Maga, G., Tyrosine kinases as essential cellular cofactors and potential therapeutic targets for human immunodeficiency virus infection. Cell. Mol. Biol. 2012, 58 (1): 31-43.
50. Sandalli, C., Singh, K., and Modak, M. J., Characterization of catalytic carboxylate triad in non-replicative DNA polymerase III (pol E) of Geobacillus kaustophilus HTA. Cell. Mol. Biol. 2012, 58 (1): 44-49.
51. Kaushal, A., Kumar, D., Khare, S. and Kumar, A., speB gene as a specific genetic marker for early detection of rheumatic heart disease in human. Cell. Mol. Biol. 2012, 58 (1): 50-54.
52. Datta, J. and Lal, N., Application of molecular markers for genetic discrimination of fusarium wilt pathogen races affecting chickpea and pigeonpea in major regions of India. Cell. Mol. Biol. 2012, 58 (1): 55-65.
53. Siddiqi, N. J., Alhomida, A. S., Khan, A. H. and Onga, W.Y., Study on the distribution of different carnitine fractions in various tissues of bovine eye. Cell. Mol. Biol. 2012, 58 (1): 66-70.
54. Ong, Y. T., Kirby, K. A., Hachiya, A., Chiang, L. A., Marchand, B., Yoshimura, K., Murakami, T., Singh, K., Matsushita, S. and Sarafianos, S. G., Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 GP120 v3 loop. Cell. Mol. Biol. 2012, 58 (1): 71-79.
55. Singh, J., Gautam, S. and Bhushan Pant, A., Effect of UV-B radiation on UV absorbing compounds and pigments of moss and lichen of Schirmacher Oasis region, East Antarctica. Cell. Mol. Biol. 2012, 58 (1): 80-84.
56. Singh, V. P., Srivastava, P. K., and Prasad, S. M., Impact of low and high UV-B radiation on the rates of growth and nitrogen metabolism in two cyanobacterial strains under copper toxicity. Cell. Mol. Biol. 2012, 58 (1): 85-95.
57. Datta, J. and Lal, N., Temporal and spatial changes in phenolic compounds in response Fusarium wilt in chickpea and pigeonpea. Cell. Mol. Biol. 2012, 58 (1): 96-102.
58. Sharma, R. K., JAISWAL, S. K., Siddiqi, N. J., and Sharma, B., Effect of carbofuran on some biochemical indices of human erythrocytes in vitro. Cell. Mol. Biol. 2012, 58 (1): 103-109.
59. Singh, A. K., Singh, S. and Singh, M. P., Bioethics A new frontier of biological Science. Cell. Mol. Biol. 2012, 58 (1): 110-114.
60. Adedeji, A. O., Singh, K. and Sarafianos, S. G., Structural and biochemical basis for the difference in the helicase activity of two different constructs of SARS-CoV helicase. Cell. Mol. Biol. 2012, 58 (1): 115-121.
61. Singh, S., Choudhuri, G., Kumar, R. and Agarwal, S., Association of 5, 10-methylenetetrahydrofolate reductase C677T polymorphism in susceptibility to tropical chronic pancreatitis in North Indian population. Cell. Mol. Biol. 2012, 58 (1): 122-127.
62. Sharma, R. K., Rai, K. D. and Sharma, B., In vitro carbofuran induced micronucleus formation in human blood lymphocytes. Cell. Mol. Biol. 2012, 58 (1): 128-133.
63. Naraian, R., Ram, S., Kaistha S. D. and Srivastava J., Occurrence of plasmid linked multiple drug resistance in bacterial isolates of tannery effluent. Cell. Mol. Biol. 2012, 58 (1): 134-141.
64. Pandey, A. K., Mishra, A. K., And Mishra, A., Antifungal and antioxidative potential of oil and extracts, respectively derived from leaves of Indian spice plant Cinnamomum tamala. Cell. Mol. Biol. 2012, 58 (1): 142-147.
65. Mishra, N., and Rizvi, S. I., Quercetin modulates na/k atpase and sodium hydrogen exchanger in type 2 diabetic erythrocytes. Cell. Mol. Biol. 2012, 58 (1): 148-152.
66. Kumar, A., Sharma, B. and Pandey, R. S., Assessment of stress in effect to pyrethroid insecticides, λ-cyhalothrin and cypermethrin in a freshwater fish, Channa punctatus (Bloch). Cell. Mol. Biol. 2012, 58 (1): 153-159.
67. Srivastava N., Sharma, R. K., Singh, N. and Sharma, B., Acetylcholinesterase from human erythrocytes membrane: a screen for evaluating the activity of some traditional plant extracts. Cell. Mol. Biol. 2012, 58 (1): 160-169.
68. Singh, M.P., Pandey, A. K., Vishwakarma S. K., Srivastava, A. K. and Pandey, V. K., Extracellular Xylanase Production by Pleurotus species on Lignocellulosic Wastes under in vivo Condition using Novel Pretreatment. Cell. Mol. Biol. 2012, 58 (1): 170-173.
69. Kumar, S., Sharma, U. K., Sharma, A. K., Pandey, A. K., Protective efficacy of Solanum xanthocarpum root extracts against free radical damage: phytochemical analysis and antioxidant effect. Cell. Mol. Biol. 2012, 58 (1): 174-181.
70. Shukla, A., Singh, A., Singh, A., Pathak, L.P., Shrivastava, N., Tripathi, P. K., Singh, K. and Singh, M.P., Inhibition of P. falciparum pfATP6 by curcumin and its derivatives: A bioinformatic Study. Cell. Mol. Biol. 2012, 58 (1): 182-186.
71. Parveen, A., Rizvi, S. H. M., Gupta, A., Singh, R., Ahmad, I., Mahdi, F., and Mahdi, A. A., NMR-based metabonomics study of sub-acute hepatotoxicity induced by silica nanoparticles in rats after intranasal exposure. Cell. Mol. Biol. 2012, 58 (1): 196-203.